Tag Archives: Prescription Overutilization

IMS Health data for 2009 creates an interesting picture of global drug sales and growth in specific therapeutic classes. WBC (wbcbaltimore.com) has taken a look and found that the global picture is clearly different when compared to  U.S. pharmacy benefit plan sponsor drug spend.  In the U.S., antipsychotics were the leading therapeutic class with $14.6 billion in sales. […]

A somewhat surprising report was released by Thomson Reuters regarding the wasteful spending practices within the American healthcare system. Not that system inefficiencies, unnecessary testing and good old-fashioned fraud should come as any surprise to those who follow this stuff, but it was the degree that caught my eye. Their conclusion is that big dollars […]